clinical stage biopharmaceutical company creating therapies for metabolic diseases
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2025 | THE KPM GROUP DC LLC |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | |
| 2025 | THE KPM GROUP DC LLC |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | |
| 2025 | THE KPM GROUP DC LLC |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | |
| 2025 | THE KPM GROUP DC LLC |
2nd Quarter (Apr 1 - June 30) AMENDED |
— |
| Firm | Filings | Expenses |
|---|---|---|
| THE KPM GROUP DC LLC | 16 | — |
| Issue | Activities |
|---|---|
| Pharmacy | 5 |
| Health Issues | 5 |